Product Theater

Thyroid Eye Disease (TED): Early Diagnosis, Referral, and Treatment with TEPEZZA® (teprotumumab-trbw) presented by Horizon Therapeutics

Thursday, May 4, 2023

2:30 PM – 3:15 PM

Location: Explore Learning Lab - Exhibit Hall - Summit Building - Level 2

Session Speaker(s)

Todd Frieze, MD

Director of Thyroid Services
Duke University, Department of Medicine, Division of Endocrinology, Metabolism and Nutrition, United States

Please join us as we discuss emerging data on the pathophysiology of Thyroid Eye Disease (TED), including the role of insulin-like growth factor-1 receptor (IGF-1R), and the treatment of TED. We will also explore how the heterogeneity of TED may lead to challenges in diagnosis, as well as the critical role of the endocrinologist in the multidisciplinary management of TED.

This symposium is organized by Horizon Therapeutics. This presentation is intended for US-based healthcare professionals.